Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Precision Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global precision medicine market reached a value of US$ XX Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Precision medicine is a medical approach to prevent and diagnose diseases by relying on an individual variability of genes, environment, and lifestyle. It assists in predicting the susceptibility to a disease, improving disease detection and progression, customizing strategies, and prescribing effective drugs. It also aids in making associated healthcare decisions, improving care quality, and eliminating trial-and-error inefficiencies. Moreover, as it reduces the time, cost, and failure rate of pharmaceutical clinical trials, precision medicine is widely utilized in diagnosing chromosomal abnormalities of the fetus and cancer, guiding therapy for chronic diseases and predicting the risk of passing on genetic disorders to offspring.

Precision Medicine Market Trends:

At present, there is a considerable rise in the use of precision medicine techniques to understand the coronavirus disease (COVID-19) susceptibility, measure its impact, and discover potential therapies. This represents one of the key factors strengthening the growth of the market. Apart from this, due to the increasing prevalence of cancer and the growing number of drug candidates under clinical trials, there is a surge in need for precision medicine methods across the globe. This, in confluence with the significantly improving healthcare infrastructure worldwide and continuous funding in research and development (R&D) activities, is contributing to market growth. Furthermore, leading players are introducing cost-effective, cutting-edge techniques, such as whole-genome sequencing and targeted sequencing, which find extensive applications in the study of genomes and the creation of personalized therapies for treating different illnesses. This, along with the rising adoption of big data in precision medicine that helps analyze the patient electronic health record and provide improved clinical decision support, is creating a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global precision medicine market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, technology, application and end user.

Breakup by Product:

  • Consumables
  • Instruments
  • Services
     

Breakup by Technology:

  • Big Data Analytics
  • Bioinformatics
  • Gene Sequencing
  • Drug Discovery
  • Companion Diagnostics
  • Others
     

Breakup by Application:

  • Oncology
  • Central Nervous System (CNS)
  • Immunology
  • Respiratory Medicine
  • Infections
  • Others
     

Breakup by End User:

  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharma and Biotech Companies
  • Healthcare IT Firms
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AstraZeneca plc, Bayer AG, bioMérieux SA, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Merck KGaA, Novartis AG, Pfizer Inc., Qiagen N.V., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Product, Technology, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AstraZeneca plc, Bayer AG, bioMérieux SA, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Merck KGaA, Novartis AG, Pfizer Inc., Qiagen N.V., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global precision medicine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global precision medicine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global precision medicine market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Precision Medicine Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Consumables
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Instruments
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Services
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Technology
    7.1    Big Data Analytics
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Bioinformatics
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Gene Sequencing
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Drug Discovery
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Companion Diagnostics
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by Application
    8.1    Oncology
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Central Nervous System (CNS)
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Immunology
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Respiratory Medicine
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Infections
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Others
        8.6.1 Market Trends
        8.6.2 Market Forecast
9    Market Breakup by End User
    9.1    Hospitals and Clinics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Diagnostic Centers
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Pharma and Biotech Companies
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Healthcare IT Firms
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    AstraZeneca plc
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Bayer AG
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    bioMérieux SA
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
           15.3.3.3 Financials
           15.3.3.4 SWOT Analysis
        15.3.4    Bristol-Myers Squibb Company
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    Eli Lilly and Company
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
           15.3.5.4 SWOT Analysis
        15.3.6    F. Hoffmann-La Roche AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 SWOT Analysis
        15.3.7    Illumina Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
           15.3.7.4 SWOT Analysis
        15.3.8    Laboratory Corporation of America Holdings
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Merck KGaA
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Novartis AG
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    Pfizer Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Qiagen N.V.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis
        15.3.13    Quest Diagnostics Incorporated
           15.3.13.1 Company Overview
           15.3.13.2 Product Portfolio
           15.3.13.3 Financials
           15.3.13.4 SWOT Analysis
        15.3.14    Thermo Fisher Scientific Inc.
           15.3.14.1 Company Overview
           15.3.14.2 Product Portfolio
           15.3.14.3 Financials
           15.3.14.4 SWOT Analysis

List of Figures

Figure 1: Global: Precision Medicine Market: Major Drivers and Challenges
Figure 2: Global: Precision Medicine Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Precision Medicine Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Precision Medicine Market: Breakup by Product (in %), 2020
Figure 5: Global: Precision Medicine Market: Breakup by Technology (in %), 2020
Figure 6: Global: Precision Medicine Market: Breakup by Application (in %), 2020
Figure 7: Global: Precision Medicine Market: Breakup by End User (in %), 2020
Figure 8: Global: Precision Medicine Market: Breakup by Region (in %), 2020
Figure 9: Global: Precision Medicine (Consumables) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Precision Medicine (Consumables) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Precision Medicine (Instruments) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Precision Medicine (Instruments) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Precision Medicine (Services) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Precision Medicine (Services) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Precision Medicine (Big Data Analytics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Precision Medicine (Big Data Analytics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Precision Medicine (Bioinformatics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Precision Medicine (Bioinformatics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Precision Medicine (Gene Sequencing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Precision Medicine (Gene Sequencing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Precision Medicine (Drug Discovery) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Precision Medicine (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Precision Medicine (Companion Diagnostics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Precision Medicine (Companion Diagnostics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Precision Medicine (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Precision Medicine (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Precision Medicine (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Precision Medicine (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Global: Precision Medicine (Central Nervous System-CNS) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Global: Precision Medicine (Central Nervous System-CNS) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Global: Precision Medicine (Immunology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Global: Precision Medicine (Immunology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Global: Precision Medicine (Respiratory Medicine) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Global: Precision Medicine (Respiratory Medicine) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Global: Precision Medicine (Infections) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Global: Precision Medicine (Infections) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Global: Precision Medicine (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Global: Precision Medicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Global: Precision Medicine (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Global: Precision Medicine (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Global: Precision Medicine (Diagnostic Centers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Global: Precision Medicine (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Global: Precision Medicine (Pharma and Biotech Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Global: Precision Medicine (Pharma and Biotech Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Global: Precision Medicine (Healthcare IT Firms) Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Global: Precision Medicine (Healthcare IT Firms) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Global: Precision Medicine (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Global: Precision Medicine (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: North America: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: North America: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: United States: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: United States: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Canada: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Canada: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: Asia-Pacific: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: Asia-Pacific: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: China: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: China: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Japan: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Japan: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: India: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: India: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: South Korea: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: South Korea: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Australia: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Australia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Indonesia: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Indonesia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Others: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Europe: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Europe: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Germany: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Germany: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: France: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: France: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: United Kingdom: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 78: United Kingdom: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 79: Italy: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 80: Italy: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Spain: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 82: Spain: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 83: Russia: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 84: Russia: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 85: Others: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 86: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Latin America: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 88: Latin America: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 89: Brazil: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 90: Brazil: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 91: Mexico: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 92: Mexico: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 93: Others: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 94: Others: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 95: Middle East and Africa: Precision Medicine Market: Sales Value (in Million US$), 2015 & 2020
Figure 96: Middle East and Africa: Precision Medicine Market: Breakup by Country (in %), 2020
Figure 97: Middle East and Africa: Precision Medicine Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 98: Global: Precision Medicine Industry: SWOT Analysis
Figure 99: Global: Precision Medicine Industry: Value Chain Analysis
Figure 100: Global: Precision Medicine Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Precision Medicine Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Precision Medicine Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Precision Medicine Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 4: Global: Precision Medicine Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 5: Global: Precision Medicine Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 6: Global: Precision Medicine Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Precision Medicine Market: Competitive Structure
Table 8: Global: Precision Medicine Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links